Literature DB >> 22019199

The intersection between cannabis and cancer in the United States.

Daniel W Bowles1, Cindy L O'Bryant, D Ross Camidge, Antonio Jimeno.   

Abstract

In the last 15 years there has been a major shift in the laws governing medical use of cannabis in the United States. Corresponding with this change there has been escalating interest in the role that cannabis, commonly referred to as marijuana, and cannabinoids play in the care of patients with cancer. This review will examine cannabis' and cannabinoids' current and potential roles in cancer care. Specifically, we will examine five areas of cannabis medicine: (1) pharmacologic properties of cannabis; (2) its potential role in the development of human cancers, particularly smoking-related malignancies; (3) cannabinoids' potential as anti-cancer therapies; (4) cannabis and cannabinoids in the palliation of common cancer-associated symptoms; (5) current legal status of cannabis for medical purposes in the United States.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019199     DOI: 10.1016/j.critrevonc.2011.09.008

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  17 in total

1.  Therapeutic Use of Cannabis in Inflammatory Bowel Disease.

Authors:  Waseem Ahmed; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

2.  Integrating cannabis into clinical cancer care.

Authors:  D I Abrams
Journal:  Curr Oncol       Date:  2016-03-16       Impact factor: 3.677

3.  PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells.

Authors:  Yuehui Hong; Yuting Zhou; Ying Wang; Shunhua Xiao; D Joshua Liao; Qing Zhao
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

4.  Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men.

Authors:  Jordan Bechtold; Theresa Simpson; Helene R White; Dustin Pardini
Journal:  Psychol Addict Behav       Date:  2015-08-03

Review 5.  Medical marijuana for digestive disorders: high time to prescribe?

Authors:  Mark E Gerich; Robert W Isfort; Bryan Brimhall; Corey A Siegel
Journal:  Am J Gastroenterol       Date:  2014-09-09       Impact factor: 10.864

Review 6.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

Review 7.  Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

Authors:  Katherine A Belendiuk; Lisa L Baldini; Marcel O Bonn-Miller
Journal:  Addict Sci Clin Pract       Date:  2015-04-21

Review 8.  Critical appraisal of the potential use of cannabinoids in cancer management.

Authors:  Belinda J Cridge; Rhonda J Rosengren
Journal:  Cancer Manag Res       Date:  2013-08-30       Impact factor: 3.989

Review 9.  Medical marijuana in the workplace: challenges and management options for occupational physicians.

Authors:  Robert S Goldsmith; Marcelo C Targino; Gilbert J Fanciullo; Douglas W Martin; Natalie P Hartenbaum; Jeremy M White; Phillip Franklin
Journal:  J Occup Environ Med       Date:  2015-05       Impact factor: 2.162

Review 10.  Medical marijuana: A panacea or scourge.

Authors:  Surender Kashyap; Kartikeya Kashyap
Journal:  Lung India       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.